Nasus Pharma Ltd (NSRX) Price Prediction & ForecastNSRXNasus Pharma Ltd

Alphio's NSRX stock price prediction model matches the current Nasus Pharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.84 (+0.35%). The 1-week path is $2.83 (+0.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Nasus Pharma Ltd is a good buy right now due to its recent FDA clearance for NS002, which positions the company for potential growth in the allergy medication market. The stock is currently priced at $2.83, significantly below its 52-week high of $9.50, indicating a potential upside of approximately 147%. Additionally, the RSI is at 23.426, suggesting that the stock is oversold and may be due for a rebound. However, investors should be cautious of the company's ongoing net losses, which reached $5.9 million in 2025 and are projected to continue, posing a risk to short-term performance.

Nasus Pharma Ltd (NSRX) last closed at $2.8299999, losing -2.75%. These facts feed the 1-day and 1-week NSRX price prediction above.